Abstract
The importance of dopamine (DA) neurotransmission is emphasized by its direct implication in several neurological and psychiatric disorders. The DA transporter (DAT), target of psychostimulant drugs, is the key protein that regulates spatial and temporal activity of DA in the synaptic cleft via the rapid reuptake of DA into the presynaptic terminal. There is strong evidence suggesting that DAT-interacting proteins may have a role in its function and regulation. Performing a two-hybrid screening, we identified snapin, a SNARE-associated protein implicated in synaptic transmission, as a new binding partner of the carboxyl terminal of DAT. Our data show that snapin is a direct partner and regulator of DAT. First, we determined the domains required for this interaction in both proteins and characterized the DAT-snapin interface by generating a 3D model. Using different approaches, we demonstrated that (i) snapin is expressed in vivo in dopaminergic neurons along with DAT; (ii) both proteins colocalize in cultured cells and brain and, (iii) DAT and snapin are present in the same protein complex. Moreover, by functional studies we showed that snapin produces a significant decrease in DAT uptake activity. Finally, snapin downregulation in mice produces an increase in DAT levels and transport activity, hence increasing DA concentration and locomotor response to amphetamine. In conclusion, snapin/DAT interaction represents a direct link between exocytotic and reuptake mechanisms and is a potential target for DA transmission modulation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU et al (2008). Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol 74: 1101–1108.
Bjerggaard C, Fog JU, Hastrup H, Madsen K, Loland CJ, Javitch JA et al (2004). Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J Neurosci 24: 7024–7036.
Buxton P, Zhang XM, Walsh B, Sriratana A, Schenberg I, Manickam E et al (2003). Identification and characterization of Snapin as a ubiquitously expressed SNARE-binding protein that interacts with SNAP23 in non-neuronal cells. Biochem J 375: 433–440.
Cai Q, Lu L, Tian JH, Zhu YB, Qiao H, Sheng ZH (2010). Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron 68: 73–86.
Calipari ES, Ferris MJ, Salahpour A, Caron MG, Jones SR (2013). Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat Commun 4: 2720.
Calipari ES, Ferris MJ, Siciliano CA, Jones SR (2015). Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate. ACS Chem Neurosci 6: 155–162.
Carneiro AM, Ingram SL, Beaulieu J-M, Sweeney A, Amara SG, Thomas SM et al (2002). The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J Neurosci 22: 7045–7054.
Carvelli L, Blakely RD, DeFelice LJ (2008). Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc Natl Acad Sci USA 105: 14192–14197.
Chheda MG, Ashery U, Thakur P, Rettig J, Sheng ZH (2001). Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex. Nat Cell Biol 3: 331–338.
De Gois S, Slama P, Pietrancosta N, Erdozain AM, Louis F, Bouvrais-Veret C et al (2015). Ctr9, a protein in the transcription complex Paf1, regulates dopamine transporter activity at the plasma membrane. J Biol Chem 290: 17848–17862.
Di Giovanni J, Sheng Z-H (2015). Regulation of synaptic activity by snapin-mediated endolysosomal transport and sorting. EMBO J 34: 2059–2077.
Egaña LA, Cuevas RA, Baust TB, Parra LA, Leak RK, Hochendoner S et al (2009). Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J Neurosci 29: 4592–4604.
Eriksen J, Jorgensen TN, Gether U (2010). Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges. J Neurochem 113: 27–41.
Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N et al (2006). Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51: 417–429.
Fon EA, Edwards RH (2001). Molecular mechanisms of neurotransmitter release. Muscle Nerve 24: 581–601.
Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283: 397–401.
German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE (2015). Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease. Pharmacol Rev 67: 1005–1024.
Giros B, Caron MG (1993). Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14: 43–49.
Giros B, El Mestikawy S, Bertrand L, Caron MG (1991). Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295: 149–154.
Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606–612.
Gowthaman R, Silvester AJ, Saranya K, Kanya KS, Archana NR (2006). Modeling of the potential coiled-coil structure of snapin protein and its interaction with SNARE complex. Bioinformation 1: 269–275.
Grace AA (2016). Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 17: 524–532.
Granata A, Koo SJ, Haucke V, Schiavo G, Warner TT (2011). CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process. EMBO J 30: 181–193.
Granata A, Watson R, Collinson LM, Schiavo G, Warner TT (2008). The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J Biol Chem 283: 7568–7579.
Holton KL, Loder MK, Melikian HE (2005). Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat Neurosci 8: 881–888.
Ilardi JM, Mochida S, Sheng ZH (1999). Snapin: a SNARE-associated protein implicated in synaptic transmission. Nat Neurosci 2: 119–124.
Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998). Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95: 4029–4034.
King RD, Sternberg MJ (1996). Identification and application of the concepts important for accurate and reliable protein secondary structure prediction. Protein Sci 5: 2298–2310.
Lee HH, Nemecek D, Schindler C, Smith WJ, Ghirlando R, Steven AC et al (2012). Assembly and architecture of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J Biol Chem 287: 5882–5890.
Lee K-H, Kim M-Y, Kim D-H, Lee Y-S (2004). Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter. Neurochem Res 29: 1405–1409.
Lin K, Simossis VA, Taylor WR, Heringa J (2005). A simple and fast secondary structure prediction method using hidden neural networks. Bioinformatics 21: 152–159.
Lin Z, Canales JJ, Björgvinsson T, Thomsen M, Qu H, Liu Q-R et al (2011). Monoamine transporters: vulnerable and vital doorkeepers. Prog Mol Biol Transl Sci 98: 1–46.
Martins D, Mehta MA, Prata D (2017). The “highs and lows” of the human brain on dopaminergics: Evidence from neuropharmacology. Neurosci Biobehav Rev 80: 351–371.
Miranda M, Sorkina T, Grammatopoulos TN, Zawada WM, Sorkin A (2004). Multiple molecular determinants in the carboxyl terminus regulate dopamine transporter export from endoplasmic reticulum. J Biol Chem 279: 30760–30770.
Navarro A, Encinar JA, López-Méndez B, Aguado-Llera D, Prieto J, Gómez J et al (2012). Mutation of Ser-50 and Cys-66 in Snapin modulates protein structure and stability. Biochemistry 51: 3470–3484.
Pan PY, Tian JH, Sheng ZH (2009). Snapin facilitates the synchronization of synaptic vesicle fusion. Neuron 61: 412–424.
Penmatsa A, Wang KH, Gouaux E (2015). X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine. Nat Struct Mol Biol 22: 506–508.
Rickhag M, Hansen FH, Sørensen G, Strandfelt KN, Andresen B, Gotfryd K et al (2013). A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter. Nat Commun 4: 1580.
Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E et al (2008). Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci USA 105: 4405–4410.
Südhof TC (2013). Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80: 675–690.
Tian JH, Wu ZX, Unzicker M, Lu L, Cai Q, Li C et al (2005). The role of Snapin in neurosecretion: snapin knock-out mice exhibit impaired calcium-dependent exocytosis of large dense-core vesicles in chromaffin cells. J Neurosci 25: 10546–10555.
Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao W-D et al (2003). Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278: 2731–2739.
Torres GE, Sweeney AL, Beaulieu J-M, Shashidharan P, Caron MG (2004). Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci USA 101: 15650–15655.
Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI et al (2001). Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30: 121–134.
Tran VS, Marion-Audibert A-M, Karatekin E, Huet S, Cribier S, Guillaumie K et al (2004). Serotonin secretion by human carcinoid BON cells. Ann N Y Acad Sci 1014: 179–188.
Viereckel T, Dumas S, Smith-Anttila CJA, Vlcek B, Bimpisidis Z, Lagerström MC et al (2016). Midbrain gene screening identifies a new mesoaccumbal glutamatergic pathway and a marker for dopamine cells neuroprotected in Parkinson’s disease. Sci Rep 6: 35203.
Wang KH, Penmatsa A, Gouaux E (2015). Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521: 322–327.
Yachdav G, Kloppmann E, Kajan L, Hecht M, Goldberg T, Hamp T et al (2014). PredictProtein—an open resource for online prediction of protein structural and functional features. Nucleic Acids Res 42: W337–W343.
Acknowledgements
We thank David Godefroy (Plateform of Institut de la Vision, Paris, France) for his technical help in acquiring the scans of the FISH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Supplementary information
Rights and permissions
About this article
Cite this article
Erdozain, A., De Gois, S., Bernard, V. et al. Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions. Neuropsychopharmacol. 43, 1041–1051 (2018). https://doi.org/10.1038/npp.2017.217
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2017.217
This article is cited by
-
Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter
Cellular and Molecular Life Sciences (2021)
-
Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neurons
Brain Structure and Function (2019)
-
Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure
Cellular and Molecular Life Sciences (2018)
